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General materials and methods
All chemicals, unless stated otherwise, were purchased from Sigma Aldrich. Purchased starting materials were used as received unless otherwise indicated. 3'-sialyllactose and 6'-sialyllactose were purchased from Carbosynth (San Diego, CA). Anhydrous dioxane was generated via filtration through basic alumina. Polymers were isolated by gel filtration on Sephadex G-25 columns (PD-10, GE Healthcare). Solvent compositions are reported on a volume/volume basis unless otherwise noted.
Instrumentation
Column chromatography was performed on a Biotage Isolaera One automated flash chromatography system. Nuclear magnetic resonance (NMR) spectra were collected on a Bruker 300 MHz NMR spectrometer. Spectra is recorded in D 2 O or D 2 O solutions at room temperature and are reported in parts per million (ppm) on the  scale relative to the residual solvent as an internal standard (for 1 H NMR, D 2 O = 4.79 ppm). Size exclusion chromatography was performed on a Hitachi Chromaster system equipped with an RI detector and a 5 m, mixed bed, 7.8 mm I.D. x 30 cm TSKgel column (Tosoh Bioscience). Polymers were analyzed using an isocratic method with a flow rate of 0.7 mL/min in DMF (0.2% w/v LiBR, 70°C). UV-Vis experiments were performed using a quartz cuvette (10 mm path length) in a Nanodrop2000c spectrophotometer (ThermoFisher). HRMS (high resolution mass spectrometry) analysis was acquired via an Agilent 6230 ESI-TOFMS in either positive or negative ion mode. Polymer glycan ligation reactions were conducted in a Biorad MyCycler thermocycler (Hercules, CA). Graphs were generated using KaleidaGraph (Reading, PA).
Overall Scheme for Mucin Mimetic Glycopolymer Synthesis 1
General procedure for RAFT polymerization 2 of tert-butyl (3-acrylamidopropoxy)methyl carbamate monomer:
As previously described, 1 a flame-dried Schlenk flask (10 mL) equipped with a magnetic stirring bar was charged with azide chain transfer agent (5.5 mg, 9.74 µmol, 0.33 mol% with respect to tert-butyl (3-acrylamidopropoxy)methyl carbamate monomer, AIBN (0.18 mg, 1 µmol, 0.03 mol% with respect to the monomer, delivered as 100 µL of a 10.2 mM solution in anhydrous dioxane, monomer (0.031 mmol AIBN in 3 mL dioxane,), and anhydrous dioxane (650 mg). The flask was equipped with a rubber septum and filled with N 2 . The yellow solution was thoroughly degassed by three freeze-pump-thaw cycles. The flask was then allowed to warm to room temperature and then immersed into an oil bath preheated to 65 °C. After 12 hours, the viscous reaction mixture was then diluted in ether and precipitated into excess hexanes with vigorous stirring. The solid residue was then re-dissolved into ether, and precipitated again in hexanes. This precipitation procedure was repeated once more. The faintly yellow polymer was then concentrated from CHCl 3 three times to remove residual hexanes and dried under vacuum overnight to yield 1a as a pale yellow solid (518.5 mg, 68.8%). 1 
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General procedure for the synthesis of end-deprotected polymers: 1 A vial (4 mL) equipped with a magnetic stir bar was charged with 1a (257.21 mg, 2 mM) and 2.30 mL of a degassed 20 mM n-butylamine solution in THF. The vial was submerged in an ice bath and allowed to react for 3.5 hours. The reaction mixture was then diluted in ether and precipitated into excess hexanes with vigorous stirring. The precipitation step was performed three times. The polymer was concentrated from CHCl 3 three times to remove residual hexanes and dried under vacuum overnight to give polymer 1b (98.5% yield) as a white solid. 1 General procedure for the synthesis of fluorophore-labeled polymers and subsequent side chain deprotection: 2 A vial (4 mL) equipped with a magnetic stirring bar, was charged with polymer 1b (45.3 mg) and dissolved in 500 µL of a 2 mM TAMRA C 5 -maleimide (1.21 eq) solution in DMF. Following degassing by three freeze-pump-thaw cycles, the reaction mixture was stirred overnight in dark. The reaction mixture was then diluted with ether and precipitated in excess hexanes. The solution was centrifuged (1000 xg, 5 min) and solvent was replaced with fresh hexanes and resubmitted to centrifugation. The precipitation procedure was repeated once more. The polymer was then concentrated from CHCl 3 three times to remove residual hexanes and dried under vacuum. Side-chain deprotection was conducted using previously published procedures. 3 To the labeled polymer intermediate, was added 500 L of a freshly prepared solution of TMS-Cl (1M) and phenol (3M) in anhydrous DCM. The resulting solution was stirred for 2 hours. The polymer is then precipitated by ether and isolated by centrifugation (1000 xg, 3 min), washed 3x with ether, isolated using a PD-10 column, and lyophilized to afford polymer 
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General procedure for glycopolymer synthesis: 1 A PCR (0.5 mL) tube containing polymer 1, along with 1.1 eq of glycan was dissolved in sodium acetate buffer (1 M NaOAc, 1 M urea, pH 4.5) to form a 150 mM (by side chain) solution. Following reaction in a thermocycler at 50˚C for 72 hours, the mixture was submitted to an Amicon Ultra Centrifugal Filter (prewashed with Milli-Q water twice by spin dialysis and overnight incubation in Milli-Q water, 10K MWCO, Millipore), and spin dialyzed (6000 xg, 14 min.) four times using a deuterated phosphate buffered saline solution (100 mM phosphate, 150 mM NaCl, pD 7.4), discarding the flow through and filling to 500 µL each time. Then, the spin column was inverted into a clean centrifuge tube and a solution of 2a-c was collected via centrifugation (1100 xg, 3 min) and analyzed by 1 H NMR. Glycan ligation efficiency was determined by subtracting the polymer backbone protons from the total integration in the region 2.5-4.5 ppm relative to the polymer backbone methyl protons (H a , 2.4-2.8 ppm), and dividing the difference by the number of glycan protons. Table S1 . Glycopolymer ligation efficiencies (LE) and valences.
Glycopolymer ligation efficiencies were determined by subtracting polymer backbone protons (total of 7 protons) from the total integration in the region 2.5-4.5 ppm, and dividing the difference by the number of glycan protons. Glycan valency was then calculated as the product of the degree of polymerization and ligation efficiency. Microarray fabrication
Procedure for generating ADIBO-functionalized slides
To generate azadibenzocyclooctyne (ADIBO)-functionalized slides, 4 the epoxy slides were rinsed with water and allowed to react overnight at room temperature with azadibenzocyclooctyne-amine (1 mM in DMF, 10 mM DIPEA) 5 in a Coplin jar. The slides were then sonicated in methanol (2 x 15 min), rinsed with water, and centrifuged at 500 rpm for 5 min to "spin-dry," and stored at 4°C until use. Prior to printing, the slides were passivated with 1% BSA, 0.1% Tween20 for 1 hr at room temperature, washed with PBS (2 x 15 min), rinsed with water, and spin dried.
Determination of Glycan Concentration for Microarray Printing:
Using the TAMRA labeling efficiency (30%), a polymer molarity can be calculated using the dye concentration determined by UVVis absorbance at 556 nm. Being that valency represents a ratio of glycans ligated per molecule of polymer, it can be used to stoichiometrically compare moles of glycan to moles of polymer.
[ 
Procedure for microarray printing
Microarrays were fabricated on epoxide-coated glass (SuperChip, ThermoFisher) using a GIX Microplotter Desktop (Sonoplot, Middleton, WI) and analyzed using a Axon GenePix 4000B microarray scanner (Molecular Devices). For microarray experiments, all water used was doubly-distilled from a Milli-Q water purification system (Millipore). PBS solutions were prepared from a 20X PBS pH 7.5 stock solution (Amresco), filtered through a 0.22 m membrane filter, and titrated to the desired pH.
The glycopolymers were printed at various concentrations (10 M -10 mM, by glycan) on the ADIBOcoated slides at 80-85% relative humidity (in 0.005% Tween, pH 7.4). Each concentration was spotted as four replicate spots, and each slide contained 16 full sub-arrays. To improve spot morphology after printing, the slides were briefly humidified over a 80 deg C water bath and snap-dried over a dry 80 deg C glass surface. The printed slides were allowed to react overnight at 4 deg C. Following a quick rinse with water, the slides were plunged in 0.1% Triton-X/PBS for 2 min, followed by additional 15 min. to remove unbound polymers, washed in PBS (2 x 15 min.), rinsed with water, and spin dried. To create individual sub-arrays on the slide, hydrophobic boundaries were drawn (Invitrogen PAP pen) around each sub-array.
Microarray hybridization with lectins
Biotinylated Sambucus Nigra agglutinin (bSNA, Vector labs), biotinylated Ricinus Communis Agglutinin I (bRCA, Vector labs), and DyLight649-conjugated Maackia Amurensis Lectin (EY Labs) were diluted to 10 nM or 100 nM in PBS / 0.9 mM calcium / 0.4 mM magnesium / 0.02 mM manganese. Arrays were blocked in 1% BSA/PBS for 20 min, rinsed with PBS, incubated with lectins for 1 h at room temperature, and fixed for 15 min with 2% paraformaldehyde in PBS. Slides were washed with PBS/ 0.05% Tween-20, lectin binding was detected by incubating with streptavidin-conjugated Cy5 (Invitrogen) for 30 min. Results. Although RCA120 (Ricinus communis agglutinin 120) is generally known as a galactosespecific plant lectin, its binding site accommodates changes in the 6'-galactose position but not in the 3' position. Thus, in addition to lactose, galactose derivatives substituted at the 6'-position (e.g. sialyllactose) have been shown to bind to RCA120, whereas 3'-sialyllactose does not. 6 
Virus production
Two influenza strains A/PR/8/34(H1N1) and A/Aichi/2/68(H3N2) were purchased from ATCC. MDCK cells (ATCC CCL-34) were maintained in Dulbeco's modified Eagle's medium (DMEM, Cellgro) supplemented with 10% fetal calf serum (FCS). All viruses were propagated in MDCK cells that were transferred to DMEM medium supplemented with 0.2% BSA fraction V (EMD), 25mM HEPES buffer (Gibco), 2 g/ml TPCK-trypsin (Worthington Corporation), and 1% penicillin/streptomycin.
Incubation of microarrays with viruses
The arrays were blocked with 1% BSA/PBS (20 min, RT), and rinsed with PBS. Virus binding to the array was evaluated by incubating A/PR/8/34 (H1N1) at ~1000 or ~500 HAU (hemagglutinating units), or A/Aichi/2/68(H3N2) at the same HAU for 1 hr at RT. Viral stocks were concentrated using a Microcon-50 filtration system (Millipore) when necessary. Viruses were diluted in PBS (0.9 mM calcium, 0.4 mM magnesium) to the appropriate HAU concentration. Following incubation with the viruses, the slides were washed extensively in PBS and fixed with 2% para-formaldehyde in PBS for 15 min. Viral binding was detected by incubation with anti-H1 (A/California/06/09, IA-01SW-0100, eEnzyme) or anti-H3 (A/Shandong/9/99, MIA-H3-246, eEnzyme) antibodies for 30 min, followed by goat-anti-rabbit-IgGAlexa647 (A31573, Invitrogen) or goat-anti-mouse-IgG-Cy5 (A10523, Invitrogen) antibodies, respectively. Antibodies were diluted in 1% BSA/PBS/0.05% Tween20, and washed post fixation in PBS/0.05%Tween20. 
